Post Tagged with: "NASDAQ:ARNA"

Study Finds Less Life Expectancy Among Poor And Less-Educated U.S. Citizens – (ARNA, VVUS, ZLCS)

Study Finds Less Life Expectancy Among Poor And Less-Educated U.S. Citizens – (ARNA, VVUS, ZLCS)

August 8, 2012 at 12:24 pm 0 comments

For poor and less-educated U.S. citizens, life expectancy has grown only slightly over the last several decades despite the latest medical advances, researchers say. The new study reveals life expectancy for people who do not complete high school is actuallyRead More

Biotech Merger & Acquisition Volume Hits The Biggest Since 2008 – (ARNA, GILD, INCY)

Biotech Merger & Acquisition Volume Hits The Biggest Since 2008 – (ARNA, GILD, INCY)

August 6, 2012 at 1:39 pm 0 comments

Biotech merger volume across the world has hit levels not seen in four years as large pharmaceutical companies chase contracts to get access to new drugs, with bankers saying therapeutic areas including cancer, inflammation and autoimmune diseases are emerging asRead More

Biotechnology Industry Organization Says Use Of Homegrown Biotechnology Can Add More Jobs To The U.S. Economy – (GILD, ARNA, IDIX)

Biotechnology Industry Organization Says Use Of Homegrown Biotechnology Can Add More Jobs To The U.S. Economy – (GILD, ARNA, IDIX)

August 3, 2012 at 11:48 am 0 comments

The Biotechnology Industry Organization (BIO) and its member companies recently revealed that production of renewable chemicals and biobased products by means of homegrown biotechnology can create more jobs opportunities across the United States. BIO showed gratitude to Sen. Debbie StabenowRead More

Biotech Stocks Manage To Resist The Broad Market Weakness And Rough Trading Acitivty – (ARNA, DNDN, ZLCS)

Biotech Stocks Manage To Resist The Broad Market Weakness And Rough Trading Acitivty – (ARNA, DNDN, ZLCS)

August 2, 2012 at 12:47 pm 0 comments

Despite a change in the broad market which appeared during March of current year, companies in the biotechnology industry have managed to resist the general market weakness and generally rough trading environment that caused confusion among investors. Many believe bio-techRead More

Peregrine Pharmaceuticals (NASDAQ:PPHM) Leads Top Gainers For July In The Biotechnology Industry – (AMGN, BDSI, SRPT, SQNM, GILD, ARNA)

Peregrine Pharmaceuticals (NASDAQ:PPHM) Leads Top Gainers For July In The Biotechnology Industry – (AMGN, BDSI, SRPT, SQNM, GILD, ARNA)

July 31, 2012 at 12:15 pm 0 comments

Shares in the biotechnology industry, which features companies such as Amgen, Inc. (NASDAQ:AMGN) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI), were mixed on Monday with Peregrine Pharmaceuticals (NASDAQ:PPHM) and Sarepta Therapeutics Inc(NASDAQ:SRPT) leading gains for July. Omeros Corporation (NASDAQ:OMER) recently announcedRead More

Biotechnology Stocks Up With XenoPort, Inc. (NASDAQ:XNPT) On Top And StemCells, Inc. (NASDAQ:STEM) Faces Biggest Drop  – (IBIO, ARNA, AMGN, GILD, GE)

Biotechnology Stocks Up With XenoPort, Inc. (NASDAQ:XNPT) On Top And StemCells, Inc. (NASDAQ:STEM) Faces Biggest Drop – (IBIO, ARNA, AMGN, GILD, GE)

July 27, 2012 at 12:39 pm 0 comments

Biotechnology stocks were up yesterday with XenoPort, Inc. (NASDAQ:XNPT) and Ibio Inc (AMEX:IBIO) leading gains while StemCells, Inc. (NASDAQ:STEM) faced the biggest fall. XenoPort shares boosted after pricing 6.15M  of common stock at $6.50 while IBIO has formed a newRead More

BioNJ  President Considers IPO As A Major Source For Cash – (ARNA, QCOR, IBIO, GE, STEM)

BioNJ President Considers IPO As A Major Source For Cash – (ARNA, QCOR, IBIO, GE, STEM)

July 26, 2012 at 12:36 pm 0 comments

For biotech companies it is now easy to go public after the federal JOBS Act, but the head of the state’s biotech group said the result of Morristown-based Durata Therapeutics Inc (NASDAQ:DRTX) market debut last week is giving other NewRead More

Top Gainers For 2012 Among Biotech Stocks – (SPPI, ARNA, GILD, CELG, BDSI, THLD, SRPT, DNDN)

Top Gainers For 2012 Among Biotech Stocks – (SPPI, ARNA, GILD, CELG, BDSI, THLD, SRPT, DNDN)

July 25, 2012 at 1:48 pm 0 comments

Biotechnology industry, which features companies such as Gilead Sciences, Inc. (NASDAQ:GILD) and Celgene Corporation (NASDAQ:CELG), is turning out to be a favorite among investors trying to  raise their alternatives. The indsutry gains so far this year are led by BioDeliveryRead More

List Of Key Pending FDA Drug Approval Decisions Between July and February 2013– (ARNA, STEM, VVUS)

List Of Key Pending FDA Drug Approval Decisions Between July and February 2013– (ARNA, STEM, VVUS)

July 24, 2012 at 1:28 pm 0 comments

An updated list of biotech and pharmaceutical companies that have pending FDA drug approval decisions for the remainder of the year and into early 2013 has been released. The calendar provides you the most important U.S. regulatory events including FDARead More

The U.S. Weight Loss Market Expected to be Worth More Than $60 Billion Annually – (PFE, VVUS, ARNA)

The U.S. Weight Loss Market Expected to be Worth More Than $60 Billion Annually – (PFE, VVUS, ARNA)

July 20, 2012 at 12:53 pm 0 comments

The U.S. Food and Drug Administration, after a 13-year dry spell, recently provided an approval for two new drugs including Belviq and Qsymia. The question will be about how to get a prescription for them. The answer may perhaps dependRead More